ONO Pharmaceutical Co ( ($JP:4528) ) has issued an update. ONO Pharmaceutical Co., Ltd. reported a 7% increase in revenue for the second quarter ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Development follows company’s ₹350-crore investment in India to expand research, manufacturing, and sustainability-led ...

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...

CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, ...

As pharmaceuticals were granted most-favored-nation (MFN) treatment in the Korea-U.S. tariff negotiations, the domestic pharmaceutical and biotech industries have shown signs of relief. In particular, ...

Key Points Added 4,306,363 Teva shares, an estimated $75.64 million trade based on the average quarterly price for Q3 2025 Transaction represents a 0.68% increase in reportable U.S. equity assets ...

BioMarin Pharmaceutical (NASDAQ: BMRN) reported its third-quarter earnings after market close Monday, and they were good ...

In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s partnership with NVIDIA to develop an AI supercomputer for drug discovery, a surge in biotech funding rounds and public offerings, and ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most profitable biotech stocks to buy. Wells Fargo maintained a Buy ...

Daewoong Pharmaceutical (Co-CEOs Seong-Soo Park and Chang-Jae Lee) announced that its first-in-class idiopathic pulmonary ...